Company · CIK 0001340752
Molecular Insight Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
MA
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-11-136095 · 501.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-126307 · 776.7 KBSEC(opens sec.gov)
- SC 13G/AMolecular Insight Pharmaceuticals, Inc.0001442757-11-000012 · 9.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-102933 · 317.7 KBSEC(opens sec.gov)
- SC 13G/AMolecular Insight Pharmaceuticals, Inc.0001442757-11-000005 · 12.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-068711 · 452.3 KBSEC(opens sec.gov)
- SC 13D/AMolecular Insight Pharmaceuticals, Inc.0001193125-11-062488 · 107.3 KBSEC(opens sec.gov)
- SC 13D/AMolecular Insight Pharmaceuticals, Inc.0000905148-11-000608 · 59.7 KBSEC(opens sec.gov)
- SC 13D/AMolecular Insight Pharmaceuticals, Inc.0001193125-11-060765 · 27.5 KBSEC(opens sec.gov)
- SC 13D/AMolecular Insight Pharmaceuticals, Inc.0000950123-11-023580 · 26.9 KBSEC(opens sec.gov)
Insiders
- Abdalian Charles H JrVP of Finance and CFO
- Attarian Mark AInterim EVP & CFO
- Babich John WDirector, Exec. VP, CSO and Pres. of R&D
- Barlow David S10% Owner
- Barrett John ASr. V.P. of Preclinical Dev
- Borys NicholasChief Medical Officer
- BRODY KENNETH DReference Footnote 1
- BROSENS FRANKReference footnote 1
- DONDERO JAMES DSee Footnote 1
- FEINBERG STEPHEN10% Owner
Tickers
No tickers on record.
Addresses
business
160 SECOND STREET
CAMBRIDGE, MA, 02142
mailing
160 SECOND STREET
CAMBRIDGE, MA, 02142
Same industry